Aug 10, 2021 - Aug 11, 2021 / NTS GMT
Laura Kathryn Chico - Wedbush Securities Inc., Research Division - SVP of Equity Research
Thanks, everybody, for joining us. My name is Laura Chico. I'm the senior biotech analyst here at Wedbush. So with our next panel, we will be discussing novel approaches in neuro. And I'm not only extremely excited about our speaker lineup today, but also a little awestruck by the collective years of experience that our panelists bring together here and confirming with everybody, it works out to be about 95 years of experience on our panel today. So pretty amazing.
Going around the Zoom room, though, we have Aptinyx CEO, Norbert Riedel; CEO of Denali Therapeutics, Ryan Watts; Sage Therapeutics CEO, Barry Greene; and Karuna Therapeutics CEO, Steve Paul. Gentlemen, thank you all to -- thanks to all of you for joining us today.
Just to set the stage, we are going to have each of our panelist start off by giving a brief introduction to themselves and their companies. I suspect everybody in the audience is probably already largely familiar with everybody, but we'll then transition to our panel
Denali Therapeutics Inc at Wedbush PacGrow Healthcare Conference (Virtual) Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers